Barclays PLC 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-12 3:35 pm Sale | 2025-09-30 | 13G | Myriad Genetics, Inc. MYGN | Barclays PLC | 3,939,238 4.230% | -960,713 (-19.61%) | Filing |
| 2025-08-12 4:06 pm Purchase | 2025-06-30 | 13G | Myriad Genetics, Inc. MYGN | Barclays PLC | 4,899,951 5.310% | 4,899,951 (New Position) | Filing |